Recent News for GBT - Global Blood Therapeutics, Inc.

Date Title
Dec 9 Biotech stocks are producing outsized gains — here’s how to get your share
Dec 7 Why Is Global Blood (GBT) Up 68.2% Since Last Earnings Report?
Dec 6 Did Hedge Funds Drop The Ball On Global Blood Therapeutics Inc (GBT)?
Dec 6 The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
Dec 5 The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission
Dec 4 The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug
Dec 4 Global Blood Therapeutics: Oxbryta Is Aimed For Success
Dec 2 Global Blood: Beware Of This Key Investment Risk As Voxelotor Enters Commercialization
Dec 2 Global Blood Therapeutics Is Poised to Rally Further in the Months Ahead
Nov 30 Stocks To Watch: ViacomCBS, Amazon's AWS Event And Conference Blitz
Nov 29 Biotech Tops in November: Best ETFs & Stocks
Nov 29 The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG
Nov 29 The Zacks Analyst Blog Highlights: Intercept, CymaBay, Amgen, Global Blood Therapeutics and ChemoCentryx
Nov 29 Global Blood (GBT) in Focus: Stock Moves 5.2% Higher
Nov 27 Why Gold is Headed to Zero -- And What You Should Buy Instead
Nov 27 Biotech Stock Roundup: CBAY Falls, CCXI Gains, Amgen Acquires Otezla & More
Nov 27 The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
Nov 27 Global Blood Therapeutics: Oxbryta Is Finally Approved
Nov 27 Global Blood's (GBT) Oxbryta Secures FDA Approval for SCD
Nov 27 Why Biotech ETFs Surged in Monday's Trading Session
Nov 26 Global Blood Therapeutics: FDA Approval Of Oxbryta Moves Company Into A Large Market Opportunity
Nov 26 This Biotech Broke Out Bullishly — But Couldn't Hold Onto That Gain
Nov 26 NTNX, DKS among premarket gainers
Nov 26 Global Blood Therapeutics stock is up on sickle cell therapy approval
Nov 26 The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug

Back to the Main GBT Page...